In tumoral cells derived from the insulin-producing rat cell line RINm5F, both low- and high-Km glucose-phosphorylating enzymic activities were present. The hexokinase-like enzyme was inhibited by glucose 6-phosphate and displayed a greater affinity for but lower maximal velocity with α-d-glucose than β-d-glucose. A comparable anomeric behavior of hexokinase was observed in breast cancer (MCF-7) and lymphocytic leukemia (P388) cells. Thus, the anomeric specificity of hexokinase in tumoral cells was not different from that recently characterized in normal mammalian cells.

1

This work was supported by grants from the Belgian Foundation for Scientific Medical Research and Belgian Ministry of Scientific Policy.

This content is only available via PDF.
©1985 American Association for Cancer Research.
1985
Cancer Research, Inc.